Advertisement
Screener

ALPHA TEKNOVA, INC. (TKNO) Debt / Equity

Alpha Teknova, Inc. Debt/Equity Ratio

The debt/equity ratio shows how much a company has borrowed for every dollar its shareholders have put in. It is long-term debt, both the part due within a year and the rest, divided by shareholder equity, shown as a multiple with both amounts in the table. A higher ratio means the company relies more on borrowed money than on shareholder capital. Because equity shrinks through buybacks or losses, the ratio can rise even when debt is unchanged, and it has no meaning when equity is negative. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

  • Alpha Teknova, Inc. debt/equity ratio for the quarter ending 2025-12-31 was 0.19, a 16.56% increase year-over-year.
  • Alpha Teknova, Inc. debt/equity ratio for the quarter ending 2025-09-30 was 0.18, a 17.35% increase year-over-year.
  • Alpha Teknova, Inc. debt/equity ratio for the quarter ending 2025-06-30 was 0.17, a 1.82% increase year-over-year.
  • Alpha Teknova, Inc. debt/equity ratio for the quarter ending 2025-03-31 was 0.17.
  • Alpha Teknova, Inc. debt/equity ratio for fiscal 2025 was 0.19, a 16.56% increase from fiscal 2024.
  • Alpha Teknova, Inc. debt/equity ratio for fiscal 2024 was 0.16, a 11.23% increase from fiscal 2023.
  • Alpha Teknova, Inc. debt/equity ratio for fiscal 2023 was 0.15.
Available history
2022-12-31 to 2025-12-31
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2025-12-310.19$13.12M$68.78M
2025-09-300.18$13.08M$72.65M
2025-06-300.17$13.03M$76.06M
2025-03-310.17$12.99M$78.61M
2024-12-310.16$13.49M$82.39M
2024-09-300.15$13.39M$87.27M
2024-06-300.17$13.28M$78.93M
2023-12-310.15$13.25M$90.04M
2023-06-300.51$44.32M$86.21M
2022-12-310.22$21.98M$99.89M

Annual Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2025-12-310.19$13.12M$68.78M
2024-12-310.16$13.49M$82.39M
2023-12-310.15$13.25M$90.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92